Cargando…
Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson’s Disease
Glial cell line-derived neurotrophic factor (GDNF) supports the growth and survival of dopaminergic neurons. CNS gene delivery currently relies on invasive intracerebral injection to transit the blood-brain barrier. Non-viral gene delivery via systematic transvascular route is an attractive alternat...
Autores principales: | Fan, Ching-Hsiang, Ting, Chien-Yu, Lin, Chung‐Yin, Chan, Hong-Lin, Chang, Yuan-Chih, Chen, You-Yin, Liu, Hao-Li, Yeh, Chih-Kuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726227/ https://www.ncbi.nlm.nih.gov/pubmed/26786201 http://dx.doi.org/10.1038/srep19579 |
Ejemplares similares
-
Ultrasound-Triggered Effects of the Microbubbles Coupled to GDNF Plasmid-Loaded PEGylated Liposomes in a Rat Model of Parkinson's Disease
por: Yue, Peijian, et al.
Publicado: (2018) -
Combining Microbubbles and Ultrasound for Drug Delivery to Brain Tumors: Current Progress and Overview
por: Liu, Hao-Li, et al.
Publicado: (2014) -
Noninvasive and Targeted Gene Delivery into the Brain Using Microbubble-Facilitated Focused Ultrasound
por: Hsu, Po-Hung, et al.
Publicado: (2013) -
Targeted delivery of engineered auditory sensing protein for ultrasound neuromodulation in the brain
por: Wu, Chun-Yao, et al.
Publicado: (2020) -
The Future of GDNF in Parkinson's Disease
por: Manfredsson, Fredric P., et al.
Publicado: (2020)